Detalles de la búsqueda
1.
Hepatitis C virus RNA is 5'-capped with flavin adenine dinucleotide.
Nature
; 619(7971): 811-818, 2023 Jul.
Artículo
Inglés
| MEDLINE | ID: mdl-37407817
2.
Characterization of multi-DAA resistance using a novel hepatitis C virus genotype 3a infectious culture system.
Hepatology
; 78(2): 621-636, 2023 08 01.
Artículo
Inglés
| MEDLINE | ID: mdl-36999539
3.
HCV genome-wide analysis for development of efficient culture systems and unravelling of antiviral resistance in genotype 4.
Gut
; 71(3): 627-642, 2022 03.
Artículo
Inglés
| MEDLINE | ID: mdl-33833066
4.
Overcoming Culture Restriction for SARS-CoV-2 in Human Cells Facilitates the Screening of Compounds Inhibiting Viral Replication.
Antimicrob Agents Chemother
; 65(7): e0009721, 2021 06 17.
Artículo
Inglés
| MEDLINE | ID: mdl-33903110
5.
Cell Culture Studies of the Efficacy and Barrier to Resistance of Sofosbuvir-Velpatasvir and Glecaprevir-Pibrentasvir against Hepatitis C Virus Genotypes 2a, 2b, and 2c.
Antimicrob Agents Chemother
; 64(3)2020 02 21.
Artículo
Inglés
| MEDLINE | ID: mdl-31818814
6.
Neutralizing antibody and CD8+ T cell responses following BA.4/5 bivalent COVID-19 booster vaccination in adults with and without prior exposure to SARS-CoV-2.
Front Immunol
; 15: 1353353, 2024.
Artículo
Inglés
| MEDLINE | ID: mdl-38571939
7.
Differential activity of nucleotide analogs against tick-borne encephalitis and yellow fever viruses in human cell lines.
Virology
; 585: 179-185, 2023 08.
Artículo
Inglés
| MEDLINE | ID: mdl-37356253
8.
SARS-CoV-2 spike HexaPro formulated in aluminium hydroxide and administered in an accelerated vaccination schedule partially protects Syrian Hamsters against viral challenge despite low neutralizing antibody responses.
Front Immunol
; 14: 941281, 2023.
Artículo
Inglés
| MEDLINE | ID: mdl-36756130
9.
Durability and breadth of neutralisation following multiple antigen exposures to SARS-CoV-2 infection and/or COVID-19 vaccination.
EBioMedicine
; 89: 104475, 2023 Mar.
Artículo
Inglés
| MEDLINE | ID: mdl-36870117
10.
An inactivated SARS-CoV-2 vaccine induced cross-neutralizing persisting antibodies and protected against challenge in small animals.
iScience
; 26(2): 105949, 2023 Feb 17.
Artículo
Inglés
| MEDLINE | ID: mdl-36644321
11.
Versatile SARS-CoV-2 Reverse-Genetics Systems for the Study of Antiviral Resistance and Replication.
Viruses
; 14(2)2022 01 18.
Artículo
Inglés
| MEDLINE | ID: mdl-35215765
12.
Nirmatrelvir-resistant SARS-CoV-2 variants with high fitness in an infectious cell culture system.
Sci Adv
; 8(51): eadd7197, 2022 12 21.
Artículo
Inglés
| MEDLINE | ID: mdl-36542720
13.
Analysis of Neutralization Titers against SARS-CoV-2 in Health-Care Workers Vaccinated with Prime-Boost mRNA-mRNA or Vector-mRNA COVID-19 Vaccines.
Vaccines (Basel)
; 10(1)2022 Jan 04.
Artículo
Inglés
| MEDLINE | ID: mdl-35062736
14.
Protection against SARS-CoV-2 transmission by a parenteral prime-Intranasal boost vaccine strategy.
EBioMedicine
; 84: 104248, 2022 Oct.
Artículo
Inglés
| MEDLINE | ID: mdl-36088218
15.
Viral genome wide association study identifies novel hepatitis C virus polymorphisms associated with sofosbuvir treatment failure.
Nat Commun
; 12(1): 6105, 2021 10 20.
Artículo
Inglés
| MEDLINE | ID: mdl-34671027
16.
Neutralisation titres against SARS-CoV-2 are sustained 6 months after onset of symptoms in individuals with mild COVID-19.
EBioMedicine
; 71: 103519, 2021 Sep.
Artículo
Inglés
| MEDLINE | ID: mdl-34419923
Resultados
1 -
16
de 16
1
Próxima >
>>